Earnings Insights

AI-generated analysis of quarterly earnings, concall highlights, and financial performance across Indian listed companies.

How to use these insights

Each article is built from earnings call transcripts and structured rank signals. Start with the latest summary, then open the stock page for the full company view, the concall page for quarter-by-quarter commentary, and the rankings dashboard to compare peers.

Shalby Q2 FY27 earnings call: Revenue & Margins | Arthneeti

Q2 FY27

The Gurgaon hospital unit has shown strong revenue growth (+50% YoY) and is nearing cash breakeven. Key concall takeaways from Shalby Ltd's Q2 FY27 earnings…

3 Nov 2026

Samhi Hotels Q2 FY27 earnings call: Revenue & Margins | Arthneeti

Q2 FY27

Past 3 years same-store growth averaged 10.4%. Key concall takeaways from Samhi Hotels Ltd's Q2 FY27 earnings call — and how it ranks against sector peers.

3 Nov 2026

J.G.Chemicals Q2 FY27 earnings call: Revenue & Margins | Arthneeti

Q2 FY27

Management remains optimistic about order inflow and capacity utilization exceeding 80%, with no supply constraints. Key concall takeaways from J.G.Chemicals…

3 Nov 2026

Arisinfra Solutions Q2 FY27 earnings call: Revenue & Margins | Arthneeti

Q2 FY27

Contract manufacturing revenue grew 22% in H1 FY27, with sustainable/improving EBITDA margins due to better utilization and economies of scale (Page 22). Key…

3 Nov 2026

Inox India Q2 FY27 earnings call: Revenue & Margins | Arthneeti

Q2 FY27

aerospace and space sectors, including over INR1,100 crores in backlog, will be executed mostly by FY28. Key concall takeaways from Inox India Ltd's Q2 FY27…

3 Nov 2026

Lords Chloro Alkali Q2 FY27 earnings call: Revenue & Margins | Arthneeti

Q2 FY27

Post-capex, free cash flow of around INR 80 crores annually for investment in specialty chemicals or expansions. Key concall takeaways from Lords Chloro Alkali…

3 Nov 2026

GSPL Transmission Q2 FY27 earnings call: Revenue & Margins | Arthneeti

Q2 FY27

GSPL has announced investments worth more than INR 3,500 crores with a robust expansion plan underway. Key concall takeaways from GSPL Transmission Ltd's Q2…

3 Nov 2026

Dam Capital Advisors Q2 FY27: Revenue ₹54.3 Cr, PAT ₹13.5 Cr | Arthneeti

Q2 FY27

Total income for Q2 FY27: ₹54.3 Cr, up 81.0% QoQ from ₹30.0 Cr in Q1 FY27 (Page 3). Key investor presentation takeaways from Dam Capital Advisors Ltd's Q2 FY27 investor presentation…

3 Nov 2026

Metropolis Healthcare Q2 FY27 earnings call: Revenue & Margins | Arthneeti

Q2 FY27

Q2 FY27 revenue grew 16% YoY; H1 FY27 revenue growth at ~16.2%, up from 12-13% in recent years. Key concall takeaways from Metropolis Healthcare Ltd's Q2 FY27…

3 Nov 2026

UFO Moviez India Q2 FY27 earnings call: Revenue & Margins | Arthneeti

Q2 FY27

The company has healthy cash reserves: ₹1,657 million cash and ₹865 million net cash as of September 30, 2026. Key concall takeaways from UFO Moviez India…

3 Nov 2026

H.G. Infra Engineering Q2 FY27 earnings call: Revenue & Margins | Arthneeti

Q2 FY27

As of September 2026, the company's order book stood at INR 13,685 crores: . Key concall takeaways from H.G. Infra Engineering Ltd's Q2 FY27 earnings call…

3 Nov 2026

Lux Industries Q2 FY27 investor presentation: Revenue & Margins | Arthneeti

Q2 FY27

313.5 crores (Consolidated; down from Rs. Key investor presentation takeaways from Lux Industries Ltd's Q2 FY27 investor presentation — and how it ranks against sector peers.

3 Nov 2026

Indiqube Spaces Q2 FY27 earnings call: Revenue & Margins | Arthneeti

Q2 FY27

Revenue growth for H1 FY27 was 35% year-on-year, indicating strong momentum. Key concall takeaways from Indiqube Spaces Ltd's Q2 FY27 earnings call — and how…

3 Nov 2026

V-Mart Retail Q2 FY27 earnings call: Revenue & Margins | Arthneeti

Q2 FY27

Inflation and commodity price pressures may cause price rises of 5% to 6%, with potential for further increases if crude prices remain high. Key concall…

3 Nov 2026

Asahi India Glass Q2 FY27: Revenue ₹1,591 Cr, PAT ₹167.3 Cr | Arthneeti

Q2 FY27

Q2 FY27 total income (revenue) was ₹1,591 crore, marking a 36.9% year-on-year (YoY) growth from ₹1,162.2 crore in Q2 FY26. Key investor presentation takeaways from Asahi…

3 Nov 2026

Subros Q2 FY27 investor presentation: Revenue & Margins | Arthneeti

Q2 FY27

1,198.90 Cr. Key investor presentation takeaways from Subros Ltd's Q2 FY27 investor presentation — and how it ranks against sector peers.

3 Nov 2026

V2 Retail Q2 FY27 earnings call: Revenue & Margins | Arthneeti

Q2 FY27

PAT growth in H1 was 43%, with PAT margin at 2% in H1 (Page 4). Key concall takeaways from V2 Retail Ltd's Q2 FY27 earnings call — and how it ranks against…

3 Nov 2026

Chambal Fertilisers & Chemicals Q2 FY27 earnings call: Revenue & Margins | Arthneeti

Q2 FY27

Capacity utilization has reached over 83%-84%, supporting margin expansion. Key concall takeaways from Chambal Fertilisers & Chemicals Ltd's Q2 FY27 earnings…

3 Nov 2026

Kamat Hotels (India) Q2 FY27 earnings call: Revenue & Margins | Arthneeti

Q2 FY27

130-135 crore for FY’27, with cumulative EBITDA around Rs. Key concall takeaways from Kamat Hotels (India) Ltd's Q2 FY27 earnings call — and how it ranks…

3 Nov 2026

Nephrocare Health Services Q2 FY27 earnings call: Revenue & Margins | Arthneeti

Q2 FY27

Capacity utilization currently at ~74-75%, with room for organic growth alongside clinic additions. Key concall takeaways from Nephrocare Health Services Ltd's…

3 Nov 2026

Arthneeti Pro · Annual

Every earnings call this season,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access